Fusion Pharmaceuticals Inc.

The momentum for this stock is not very good. Fusion Pharmaceuticals Inc. is not a good value stock. Fusion Pharmaceuticals Inc. is not a good growth stock. Fusion Pharmaceuticals Inc. is a mediocre stock to choose.

News

AstraZeneca completes acquisition of Fusion Pharmaceuticals

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Acquisition of Fusion Pharmaceuticals Completed

PR Newswire Acquisition of Fusion Pharmaceuticals Completed Acquisition of Fusion Pharmaceuticals Completed PR Newswire HAMILTON, ON and BOSTON, June 4, 2024 HAMILTON, ONandBOSTON, June 4, 2024 /PRNewswire...\n more…

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Rating of "Hold" by Analysts

Ticker Report Fusion Pharmaceuticals Inc. (NASDAQ:FUSN - Get Free Report) has received a consensus rating of "Hold" from the fourteen analysts that are presently covering the stock, MarketBeat reports. Thirteen...\n more…

Fusion Pharmaceuticals receives final court order approving AstraZeneca deal

Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement

CNW Group - News Releases Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement Canada NewsWire HAMILTON, ON and BOSTON, May 31, 2024...\n more…